Cardinal Health, Inc. (CLH.F)
- Previous Close
95.86 - Open
95.90 - Bid 96.36 x 20000
- Ask 96.58 x 20000
- Day's Range
95.86 - 95.90 - 52 Week Range
73.08 - 106.30 - Volume
65 - Avg. Volume
32 - Market Cap (intraday)
23.56B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
41.22 - EPS (TTM)
2.35 - Earnings Date May 2, 2024
- Forward Dividend & Yield 1.88 (1.94%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
57.92
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
www.cardinalhealth.comRecent News: CLH.F
Performance Overview: CLH.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLH.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLH.F
Valuation Measures
Market Cap
23.40B
Enterprise Value
23.52B
Trailing P/E
41.23
Forward P/E
13.46
PEG Ratio (5yr expected)
0.31
Price/Sales (ttm)
0.12
Price/Book (mrq)
--
Enterprise Value/Revenue
0.11
Enterprise Value/EBITDA
12.43
Financial Highlights
Profitability and Income Statement
Profit Margin
0.30%
Return on Assets (ttm)
2.79%
Return on Equity (ttm)
--
Revenue (ttm)
216.15B
Net Income Avi to Common (ttm)
639M
Diluted EPS (ttm)
2.35
Balance Sheet and Cash Flow
Total Cash (mrq)
4.59B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.84B
Research Analysis: CLH.F
Company Insights: CLH.F
CLH.F does not have Company Insights